Contra el uso facilita de las mediciones de artículos científicos
Enero 18, 2015

The San Francisco Declaration on Research Assessment (DORA), initiated by the American Society for Cell Biology (ASCB) together with a group of editors and publishers of scholarly journals, recognizes the need to improve the ways in which the outputs of scientific research are evaluated. The group met in December 2012 during the ASCB Annual Meeting in San Francisco and subsequently circulated a draft declaration among various stakeholders. DORA as it now stands has benefited from input by many of the original signers listed below. It is a worldwide initiative covering all scholarly disciplines. We encourage individuals and organizations who are concerned about the appropriate assessment of scientific research to sign DORA.

San Francisco Declaration on Research Assessment

Putting science into the assessment of research


There is a pressing need to improve the ways in which the output of scientific research is evaluated by funding agencies, academic institutions, and other parties.

To address this issue, a group of editors and publishers of scholarly journals met during the Annual Meeting of The American Society for Cell Biology (ASCB) in San Francisco, CA, on December 16, 2012. The group developed a set of recommendations, referred to as the San Francisco Declaration on Research Assessment. We invite interested parties across all scientific disciplines to indicate their support by adding their names to this Declaration.

The outputs from scientific research are many and varied, including: research articles reporting new knowledge, data, reagents, and software; intellectual property; and highly trained young scientists. Funding agencies, institutions that employ scientists, and scientists themselves, all have a desire, and need, to assess the quality and impact of scientific outputs. It is thus imperative that scientific output is measured accurately and evaluated wisely.

The Journal Impact Factor is frequently used as the primary parameter with which to compare the scientific output of individuals and institutions. The Journal Impact Factor, as calculated by Thomson Reuters, was originally created as a tool to help librarians identify journals to purchase, not as a measure of the scientific quality of research in an article. With that in mind, it is critical to understand that the Journal Impact Factor has a number of well-documented deficiencies as a tool for research assessment. These limitations include: A) citation distributions within journals are highly skewed [1–3]; B) the properties of the Journal Impact Factor are field-specific: it is a composite of multiple, highly diverse article types, including primary research papers and reviews [1, 4]; C) Journal Impact Factors can be manipulated (or “gamed”) by editorial policy [5]; and D) data used to calculate the Journal Impact Factors are neither transparent nor openly available to the public [4, 6, 7].

Below we make a number of recommendations for improving the way in which the quality of research output is evaluated. Outputs other than research articles will grow in importance in assessing research effectiveness in the future, but the peer-reviewed research paper will remain a central research output that informs research assessment. Our recommendations therefore focus primarily on practices relating to research articles published in peer-reviewed journals but can and should be extended by recognizing additional products, such as datasets, as important research outputs. These recommendations are aimed at funding agencies, academic institutions, journals, organizations that supply metrics, and individual researchers.
A number of themes run through these recommendations:

-­‐  the need to eliminate the use of journal-based metrics, such as Journal Impact

Factors, in funding, appointment, and promotion considerations;

-­‐  the need to assess research on its own merits rather than on the basis of the journal in which the research is published; and

-­‐  the need to capitalize on the opportunities provided by online publication (such

as relaxing unnecessary limits on the number of words, figures, and references in articles, and exploring new indicators of significance and impact).
We recognize that many funding agencies, institutions, publishers, and researchers are already encouraging improved practices in research assessment. Such steps are beginning to increase the momentum toward more sophisticated and meaningful approaches to research evaluation that can now be built upon and adopted by all of the key constituencies involved.
The signatories of the San Francisco Declaration on Research Assessment support the adoption of the following practices in research assessment.

General Recommendation

1. Do not use journal-based metrics, such as Journal Impact Factors, as a surrogate measure of the quality of individual research articles, to assess an individual scientist’s contributions, or in hiring, promotion, or funding decisions.

For funding agencies

2. Be explicit about the criteria used in evaluating the scientific productivity of grant applicants and clearly highlight, especially for early-stage investigators, that the scientific content of a paper is much more important than publication metrics or the identity of the journal in which it was published.

3. For the purposes of research assessment, consider the value and impact of all research outputs (including datasets and software) in addition to research publications, and consider a broad range of impact measures including qualitative indicators of research impact, such as influence on policy and practice.

For institutions

4. Be explicit about the criteria used to reach hiring, tenure, and promotion decisions, clearly highlighting, especially for early-stage investigators, that the scientific content of a paper is much more important than publication metrics or the identity of the journal in which it was published.

5. For the purposes of research assessment, consider the value and impact of all
research outputs (including datasets and software) in addition to research publications, and consider a broad range of impact measures including qualitative indicators of research impact, such as influence on policy and practice.

For publishers

6. Greatly reduce emphasis on the journal impact factor as a promotional tool, ideally by ceasing to promote the impact factor or by presenting the metric in the context of a variety of journal-based metrics (e.g., 5-year impact factor, EigenFactor [8], SCImago [9], h-index, editorial and publication times, etc.) that provide a richer view of journal performance.

7. Make available a range of article-level metrics to encourage a shift toward assessment based on the scientific content of an article rather than publication metrics of the journal in which it was published.

8. Encourage responsible authorship practices and the provision of information about the specific contributions of each author.

9. Whether a journal is open-access or subscription-based, remove all reuse limitations on reference lists in research articles and make them available under the Creative Commons Public Domain Dedication [10].

10. Remove or reduce the constraints on the number of references in research articles, and, where appropriate, mandate the citation of primary literature in favor of reviews in order to give credit to the group(s) who first reported a finding.

For organizations that supply metrics

11. Be open and transparent by providing data and methods used to calculate all metrics.

12. Provide the data under a licence that allows unrestricted reuse, and provide computational access to data, where possible.

13. Be clear that inappropriate manipulation of metrics will not be tolerated; be explicit about what constitutes inappropriate manipulation and what measures will be taken to combat this.

14. Account for the variation in article types (e.g., reviews versus research articles), and in different subject areas when metrics are used, aggregated, or compared.

For researchers

15. When involved in committees making decisions about funding, hiring, tenure, or promotion, make assessments based on scientific content rather than publication metrics.

16. Wherever appropriate, cite primary literature in which observations are first reported rather than reviews in order to give credit where credit is due.

17. Use a range of article metrics and indicators on personal/supporting statements, as evidence of the impact of individual published articles and other research outputs [11].

18. Challenge research assessment practices that rely inappropriately on Journal Impact Factors and promote and teach best practice that focuses on the value and influence of specific research outputs.

References

  1. Adler, R., Ewing, J., and Taylor, P. (2008) Citation statistics. A report from the International Mathematical Union. www.mathunion.org/publications/report/citationstatistics0
  2. Seglen, P.O. (1997) Why the impact factor of journals should not be used for evaluating research. BMJ 314, 498–502.
  3. Editorial (2005). Not so deep impact. Nature 435, 1003–1004.
  4. Vanclay, J.K. (2012) Impact Factor: Outdated artefact or stepping-stone to journal certification. Scientometric 92, 211–238.
  5. The PLoS Medicine Editors (2006). The impact factor game. PLoS Med 3(6): e291 doi:10.1371/journal.pmed.0030291.
  6. Rossner, M., Van Epps, H., Hill, E. (2007). Show me the data. J. Cell Biol. 179, 1091–1092.
  7. Rossner M., Van Epps H., and Hill E. (2008). Irreproducible results: A response to Thomson Scientific. J. Cell Biol. 180, 254–255.
  8. http://www.eigenfactor.org/
  9. http://www.scimagojr.com/
  10. http://opencitations.wordpress.com/2013/01/03/open-letter-to-publishers
  11. http://altmetrics.org/tools/

List of Original Signers (Individuals)

1 Euan Adie Altmetric LLP

2 Elizabeth M. Adler Executive Editor, The Journal of General Physiology

3 Sharon Ahmad Executive Editor, Journal of Cell Science

4 Kurt H. Albertine Editor-­‐in-­‐Chief, The Anatomical Record

5 Bruce Alberts Editor-­‐in-­‐Chief, Science

6 José M. Amigó Professor Emeritus, Unity of Crystallography and Mineralogy, Department of Geology, University of Valencia, Spain

7 Parker Antin Editor-­‐in Chief, Developmental Dynamics

8 Simeon Arseniyadis Research Director, CNRS-­‐France

9 Detlef Axmann Professor, Department of Prosthodontics and Medical Materials, Eberhard-­‐Karls-­‐ University, Germany

10 Tonci Balic-­‐Zunic Associate Professor in Mineralogy and leader of the Crystallography & Mineralogy

Group, Natural History Museum, University of Copenhagen, Denmark

11 Joel Bernstein Professor, Department of Chemistry, New York University Abu Dhabi, United Arab Emirates

12 Stefano Bertuzzi Executive Director, American Society for Cell Biology

13 Ted Bianco Acting Director, Wellcome Trust

14 Joël Bockaert Professor, University of Montpellier 1, France; Member, Académie des Sciences

15 Elena Boldyreva Novosibirsk State University, Institute of Solid State Chemistry and Mechanochemistry, Siberian Branch of Russian Academy of Sciences

16 David Botstein Founding Editor-­‐in-­‐Chief of Molecular Biology of the Cell; Director Lewis-­‐Sigler

Institute for Integrative Genomics, Princeton University

17 Nouzha Bouhmaida Professor, Laboratoire Sciences Des Matériaux, Faculté Des Sciences, Marrakech, Morocco

18 Roque J. Calvo Executive Director, ECS – The Electrochemical Society

19 Michael Caplan Professor and Chair, Dept. of Cellular and Molecular Physiology, Yale University

20 Julio E. Celis Editor-­‐in-­‐Chief, Molecular Oncology

21 Martin Černohorský Rector emeritus, Silesian University in Opava; Professor emeritus, Masaryk University, Brno, Czech Republic

22 Vicki Chandler Gordon and Betty Moore Foundation

23 Daniel Choquet Research Director, CNRS; Director of the Interdisciplinary Institute for Neuroscience; Director of the Bordeaux Imaging Center; Member of the Academy

24 Don Cleveland President, American Society for Cell Biology; Distinguished Professor and Chair, Dept.

of Cellular and Molecular Medicine, Univ. of California, San Diego

25 Francoise Combes Observatoire de Paris and Academie des Sciences

26 Paul Courant Harold T. Shapiro Professor of Public Policy, University of Michigan

27 Brendan Crabb President, Association of Australian Medical Research Institutes; Director, The Burnet Institute, Melbourne

28 Ana Maria Cuervo co-­‐Editor-­‐in-­‐Chief of Aging Cell; Professor, Albert Einstein College of Medicine

29 Stephen Curry Professor and Chair, Department of Life Sciences, Imperial College, London

30 Antonella De Matteis Telethon Institute of Genetics and Medicine

31 Tracey DePellegrin Executive Editor, GENETICS and G3: Genes|Genomes|Genetics

32 Michel Desarménien Research Director, CNRS-­‐France

33 Danny Dolev Scientific Council, ERC; School of Engineering and Computer Science, The Hebrew University of Jerusalem

34 Athene M. Donald Cavendish Laboratory, Cambridge, UK

35 David Drubin Editor-­‐in-­‐Chief, Molecular Biology of the Cell; Professor, University of California, Berkeley

36 Barbara Ensoli Director, National AIDS Center

37 Wolfgang Eppenschwandtner Executive Coordinator, Initiative for Science in Europe (ISE)

38 Daniel Esteve Quantronics group, SPEC-­‐CEA Saclay

39 Pavel Exner Scientific Director, Doppler Institute for Mathematical Physics and AppliedMathematics Prague, Czech Republic
40 Adam P. Fagen Executive Director, Genetics Society of America
41 Sir Alan Fersht, FRS Associate Editor, PNAS
42 László Fésüs Chairman of Publications Committee, Federation of European Biochemical Societies
43 Marty Frank Executive Director, The American Physiological Society
44 Toni Gabaldón Centre for Genomic Regulation, Barcelona, Spain
45 Santiago Garcia-­‐Granda Professor, Physical Chemistry, University of Oviedo; Immediate Past-­‐President,
European Crystallographic Association
46 Juan Manuel García-­‐Ruiz Research Professor at the Consejo Superior de Investigaciones Científicas and
University of Granada
47 Fernando Garzon President, ECS – The Electrochemical Society
48 Marina Gebert Group Leader Aquatic Cell Technology, Fraunhofer Institution for Marine
Biotechnology, Luebeck, Germany
49 James Gentile Dean, Natural & Applied Sciences, Hope College; Past President, Research
Corporation for Science Advancement; former Editor-­‐in-­‐Chief, Mutation Research
50 Alexander Gerber Managing Director, German Research Center for Science & Innovation
Communication (INNOKOMM)
51 Christian Gericke Chief Executive, The Wesley Research Institute, Brisbane
52 Paul A. Gleeson Head, Department of Biochemistry and Molecular Biology, The University of
Melbourne
53 Bruce L. Goode Editor, Cytoskeleton; Professor, Biology Rosenstiel Basic Medical Sciences Research
Center, Brandeis University
54 Sharona Gordon Incoming Editor, Journal of General Physiology
55 Robert M. Graham Executive Director, Victor Chang Cardiac Research Institute, Sydney, Australia
56 Peter Gunning President, Australian Society for Biochemistry and Molecular Biology; Editor-­‐In-­‐Chief,
BioArchitecture, University of New South Wales
57 John Gurdon Former Chairman, Company of Biologists
58 Lisa Hannan Managing Editor, Traffic
59 Richard W. Hartel Editor-­‐in-­‐Chief, Journal of the American Oil Chemists’ Society
60 Carl-­‐Henrik Heldin Ludwig Institute for Cancer Research, Uppsala University, Sweden
61 Etienne Herzog Interdisciplinary Institute for NeuroScience, Bordeaux University, France
62 Dennis W. Hess Editor, ECS Journal of Solid State Science & Technology and ECS Solid State Letters
63 Heribert Hirt President, European Plant Sciences Organisation (EPSO)
64 Brian Hoal Executive Director, Society of Economic Geologists
65 Jason Hoyt Co-­‐Founder and CEO, PeerJ
66 Fabian Huettig Assistant Medical Director, Department for Prosthodontics with Section “Medical
Materials & Technology, ” Center for Dentistry and Oral Medicine, Tuebingen
67 Steve Humphries University HospitalEditor-­‐in-­‐Chief, Atherosclerosi, Official Journal of the European Atherosclerosis
Society
68 Tim Hunt Fellow of the Royal Society; Chair, The Company of Biologists.
69 Howy Jacobs Chief Editor, EMBO Reports
70 Reinhard Jahn Department of Neurobiology, MPI for Biophysical Chemistry; EMBO Publications
Advisory Committee (chair); EMBL Scientific Advisory Board (vice chair); Dean,
71 David James Göttingen Graduate School for Neurosciences, Biophysics, and Molecular BiosciencesDirector, Diabetes and Obesity Program, Garvan Institute of Medical Research;
Fellow, Australian Academy of Science
72 Mark Johnston Editor-­‐in-­‐Chief of GENETICS; Professor and Chair, Department of Biochemistry and
Molecular Genetics, the University of Colorado School of Medicine
73 Richard A.L. Jones ex-­‐Editor-­‐in-­‐Chief, European Physical Journal
74 Kozo Kaibuchi Editor-­‐in-­‐Chief of Cell Structures and Functions (the official journal of the Japanese
Society for Cell Biology)
75 Alan Kraut Executive Director, Association for Psychological Science
76 Karl Kuchler Medical University Vienna, Max F. Perutz Laboratories
77 Laurent Ladépêche Interdisciplinary Institute for NeuroScience, Bordeaux University, France
78 Fernando J. Lahoz Director, Chemical Synthesis and Homogeneous Catalysis Research Institute, Spanish
79 Pekka Lappalainen National Research Center -­‐ University of Zaragoza, Zaragoza, SpainExecutive Editor, Cytoskeleton; Research Director, Institute of Biotechnology,
80 Rebecca Laurence University of HelsinkiPublisher, F1000Research and F1000Posters
81 W. Mark Leader Publications Director, American Society for Cell Biology
82 Thomas Lemberger Chief Editor, Molecular Systems Biology
83 Maria Leptin Director, EMBO
84 Anthony Linden University of Zurich
85 Daniel Louvard Director of the Research Centre Institut Curie
86 Michael Lynch President, Genetics Society of America
87 Michael Marks Co-­‐editor, Traffic; Professor, University of Pennsylvania
88 Mark Marsh Co-­‐editor, Traffic; Director, Medical Research Council Laboratory for Molecular Cell
89 Marc A. Marti-­‐Renom BiologyAssociate Editor at PLOS Computational Biology; National Center for Genomic
90 Thomas Marwick Analysis and Centre for Genomic Regulation, Barcelona, SpainDirector, Menzies Research Institute Tasmania
91 Paul Matsudaira Head, Department of Biological Sciences, National University of Singapore
92 Iain Mattaj EMBL Director General
93 Satyajit Mayor Director, National Centre for Biological Science, Bangalore, India
94 Tom Misteli Editor-­‐in-­‐Chief, The Journal of Cell Biology
95 Thor Moeller Researcher, Institut de Génomique Fonctionnelle (IGF), CNRS
96 Lucia Monaco Chief Scientific Officer, Fondazione Telethon, Italy
97 Eric Murphy Editor-­‐in-­‐Chief, Lipids, a Journal of the American Oil Chemists’ Society
98 Valery Nakariakov President, European Solar Physics Division; Physics Department, University of
99 Susana Narotzky Warwick, UKProfessor, Cultural Anthropology, University of Barcelona, Spain
100 Helga Nowotny President, European Research Council; WWTF Vienna Science and Technology Fund
101 Paul Nurse President, The Royal Society
102 Henk Ottens President, Association of Geographical Societies in Europe EUGEO
103 Mark Patterson Executive Director, eLife
104 Eva Pebay-­‐Peyroula Professor, Joseph Fourier University, Grenoble Member of the French Academy of
105 Pedro Pereira ScienceAssociate Researcher, IBMC -­‐ Instituto de Biologia Molecular e Celular, Portugal
106 Richard N. Perham Editor-­‐in-­‐Chief, FEBS Journal
107 Alaine Peyraube Director of Research at the CNRS (France)
108 Olivier Pironneau Professor, LJLL -­‐ Analyse Numérique, Université Pierre et Marie Curie (Paris VI)
109 Heather Piwowar Cofounder, ImpactStory
110 Olivier Pourquié Editor-­‐in-­‐Chief, Development
111 Jacques Pouyssegur Research Director at CNRS, Member of French & Europea Academy, Nice
112 Alberto Prestininzi Editor-­‐in -­‐Chief, Italian Journal of Engineering Geology and Environment
113 Jason Priem Co-­‐founder, ImpactStory
114 Edward N. Pugh, Jr. Editor, Journal of General Physiology
115 Bernd Pulverer Chief Editor, The EMBO Journal; Head of Scientific Publications, EMBO
116 Marianne Quiquandon Researcher, CNRS-­‐France
117 Jordan Raff President, British Society of Cell Biology; Editor-­‐in-­‐Chief, Biology Open; Professor,
118 Francisco X. Real Cancer Cell Biology, University of Oxford.Spanish National Cancer Research Center and Universitat Pompeu Fabra
119 Alyson Reed Executive Director, Linguistic Society of America
120 Kari Rissanen Academy Professor, Department of Chemisty, University of Jyväskylä, Finland
121 Phillip J. Robinson Head, Cell Signalling Unit, Children’s Medical Research Institute
122 Mike Rossner Executive Director, The Rockefeller University Press
123 Didier Roux Member of the French Academy of Sciences
124 Anthony J. Ryan Pro Vice Chancellor, Faculty of Science, The University of Sheffield
125 Jean-­‐Louis Salager Editor-­‐in-­‐Chief, Journal of Surfactants and Detergents
126 Noel B. Salazar President, European Association of Social Anthropologists
127 Michele Saviano President of Italian Association of Crystallography, Director of Institute of
128 Randy Schekman Crystallography-­‐CNREditor-­‐in-­‐Chief, eLife
129 Sandra Schmid Cecil H. Green Distinguished Chair in Cellular and Molecular Biology; Professor and
130 Trina Schroer Chair, Department of Cell Biology, University of Texas Southwestern Medical CenterCo-­‐editor, Traffic; Professor, Johns Hopkins University
131 Ulrich Schubert Professor, Institute of Material Chemistry, Vienna University of Technology
132 Jörg Schulz Editor-­‐in-­‐Chief, Journal of Neurochemistry; Chair and Full Professor, Department of
133 André Sentenac Neurology, RWTH Aachen University, GermanyMember of the French Academy of Sciences; Former Director of a Department of
134 Robert Shepherd Biology at the CEA (Atomic Energy Commission)Director, Bionics Institute, University of Melbourne
135 Stuart Shieber Harvard University
136 Tom Stevens Co-­‐editor, Traffic; Professor, University of Oregon
137 Jennifer L. Stow Professor and Deputy Director, Research, Institute for Molecular Bioscience, The
138 Sona Strbanova University of QueenslandAssociate Professor, Centre for the History of Sciences and Humanities, Institute for
139 Marlowe Tessmer Contemporary History, Academy of Sciences of the Czech RepublicSenior Editor, The Journal of Experimental Medicine
140 Robert Tjian President, Howard Hughes Medical Institute
141 Gerrit Van Meer Dean of the Faculty of Sciences, Utrecht University
142 Petr Vanýsek Editor, Journal of The Electrochemical Society and ECS Electrochemistry Letters
143 Inder Verma Editor-­‐in-­‐Chief, Proceedings of The National Academy Of Sciences (PNAS)
144 Michael Way Editor-­‐in-­‐Chief, Journal of Cell Science
145 Heiner Weber Dean, Center for Dentistry and Oral Medicine; Chairman, Department of
146 Eric Westhof Prosthodontics, University of Tuebingen, GermanyDirecteur, Institut de biologie moléculaire et cellulaire du CNRS, Strasbourg, France
147 Kathleen Wets Publisher, F1000Prime
148 Felix Wieland Managing Editor, FEBS Letters
149 Liz Williams Executive Editor, The Journal of Cell Biology
150 Mitsuhiro Yanagida Editor-­‐in-­‐Chief, Genes to Cells
151 Alpha Yap Head, Division of Molecular Cell Biology, Institute for Molecular Bioscience, The
152 Mary Yess University of QueenslandDeputy Executive Director and Publisher, ECS -­‐ The Electrochemical Society
153 Marino Zerial Max Planck Director, Max Planck Institute of Molecular Cell Biology and Genetics,
154 Ya-­‐ping Zhang DresdenVice-­‐President, Chinese Academy of Sciences
155 Jiří Zlatuška Rector emeritus, Professor, Masaryk University, Brno, Czech Republic

List of Original Signers (Organizations)

1 Academy of Sciences of the Czech Republic (AS CR)

2 Altmetric LLP

3 American Association for the Advancement of Science (AAAS)

4 American Oil Chemists’ Society

5 American Society for Cell Biology

6 American Society of Agronomy

7 Association for Psychological Science

8 Austrian Science Fund (FWF)

9  Biology Open

10 British Society for Cell Biology

11  CBE—Life Sciences Education

12  Cell Structure and Function (a journal published by Japanese Society of Cell Biology)

13 Centro Nacional de Analisis Genomico (CNAG)

14 Crop Science Society of America

15 Czech Mathematical Society

16 Department of Cell Biology, University of Texas Southwestern Medical Center

17  Development

18  Disease Models & Mechanisms

19 ECS – The Electrochemical Society

20  eLife

21 EMBO

22 EMBO Reports

23 EuCheMS

24 European Association of Science Editors

25 European Association of Social Anthropologists

26 European Astronomical Society (EAS)

27 European Atherosclerosis Society (EAD)

28 European Council of Doctoral Candidates and Junior Researchers (EURODOC)

29 European Crystallographic Association

30 European Education Research Association (EERA)

31 European Federation for Medicinal Chemistry (EFMC)

32 European Glaucoma Society

33 European Mathematical Society

34 European Molecular Biology Laboratory

35 European Optical Society

36 European Society for Soil Conservation

37 European Society for the History of Science

38 European Sociological Association

39 Faculty of 1000

40  FEBS Journal

41  FEBS Letters

42  FEBS Open Bio

43 Federation of European Biochemical Societies

44 Fondazione Telethon

45 Garvan Institute of Medical Research

46 Genetics Society of America (GSA)

47 Gordon and Betty Moore Foundation

48 Higher Education Funding Council for England (HEFCE)

49 Howard Hughes Medical Institute

50 ImpactStory

51 Institute for Molecular Bioscience, Brisbane Australia

52 Institute of Mathematics, Academy of Sciences of the Czech Republic, Prague

53  Journal of Cell Science

54  Journal of Neurochemistry (Society Journal of the International Society of Neurochemistry)

55 Linguistic Society of America

56  Macedonian Journal of Chemistry and Chemical Engineering

57 Medical Research Council Laboratory of Molecular Cell Biology

58  Molecular Oncology

59  Molecular Biology of the Cell

60 Molecular Systems Biology

61 Nacional de Analisis Genomico (CNAG), Barcelona, Spain

62 PeerJ

63  Proceedings of The National Academy Of Sciences (PNAS)

64 Public Library of Science (PLOS)

65 Society of Chemists and Technologists of Macedonia

66 Society of Economic Geologists

67 Soil Science Society of America

68 Spanish Crystallographic Association (GE3C)

69 Swiss Academy of Medical Sciences

70 The American Physiological Society

71  The Anatomical Record

72 The Association of Australian Medical Research Institutes

73 The Bionics Institute

74  The Company of Biologists

75 The European Society for History of Science

76 The EMBO Journal

77 The International Society of Addiction Journal Editors

78  The Journal of Cell Biology

79  The Journal of Experimental Biology

80 The Macfarlane Burnet Institute for Medical Research and Public Health (Burnet Institute)

81 Victor Chang Cardiac Research Institute

82 Wellcome Trust

0 Comments

Submit a Comment

Tu dirección de correo electrónico no será publicada. Los campos requeridos están marcados *

PUBLICACIONES

Libros

Capítulos de libros

Artículos académicos

Columnas de opinión

Comentarios críticos

Entrevistas

Presentaciones y cursos

Actividades

Documentos de interés

Google académico

DESTACADOS DE PORTADA

Artículos relacionados

Trump y la ciencia

Trump’s anti-science appointees ‘drive demonisation of scholars’ With vaccine sceptics taking top White House posts, there are concerns that attacks on scientists who counter misinformation may become more extreme Jack Grove,November 18, 2024 Researchers who have...

Share This